The increasing incidence of vancomycin-resistant Enterococcus faecium (VRE) in
New York City has been described in several studies, beginning in 1989, when the New York City Department of Health documented 360 patients with VRE from almost 47% of the city's hospitals. 1 A second survey, published by the New York City Department of Health in 1993, indicated that cases of VRE had occurred in all but two small surgical hospitals in the city. 2
The incidence of VRE in New York State, while lagging behind New York City, has increased in a similar fashion: more than 50% of counties have docu- 
